DK265484A - Forbedret fremgangsmaade til fremstilling af steroidestere - Google Patents

Forbedret fremgangsmaade til fremstilling af steroidestere Download PDF

Info

Publication number
DK265484A
DK265484A DK265484A DK265484A DK265484A DK 265484 A DK265484 A DK 265484A DK 265484 A DK265484 A DK 265484A DK 265484 A DK265484 A DK 265484A DK 265484 A DK265484 A DK 265484A
Authority
DK
Denmark
Prior art keywords
easters
steroid
preparation
improved procedure
improved
Prior art date
Application number
DK265484A
Other languages
English (en)
Other versions
DK265484D0 (da
DK162100C (da
DK162100B (da
Inventor
Anders Robert Stamvik
Sten Krister Kristensson
Karl-Erik Lundvall
Original Assignee
Leo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Ab filed Critical Leo Ab
Publication of DK265484D0 publication Critical patent/DK265484D0/da
Publication of DK265484A publication Critical patent/DK265484A/da
Publication of DK162100B publication Critical patent/DK162100B/da
Application granted granted Critical
Publication of DK162100C publication Critical patent/DK162100C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Amplifiers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
DK265484A 1983-05-30 1984-05-29 Fremgangsmaade til fremstilling af steroidestere DK162100C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8303031A SE8303031D0 (sv) 1983-05-30 1983-05-30 Improved steroid esters preparation
SE8303031 1983-05-30

Publications (4)

Publication Number Publication Date
DK265484D0 DK265484D0 (da) 1984-05-29
DK265484A true DK265484A (da) 1984-12-01
DK162100B DK162100B (da) 1991-09-16
DK162100C DK162100C (da) 1992-02-24

Family

ID=20351375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK265484A DK162100C (da) 1983-05-30 1984-05-29 Fremgangsmaade til fremstilling af steroidestere

Country Status (18)

Country Link
US (1) US4537722A (da)
EP (1) EP0127829B1 (da)
JP (1) JPS6041696A (da)
AT (1) ATE32603T1 (da)
AU (1) AU560235B2 (da)
CA (1) CA1211430A (da)
DE (1) DE3469440D1 (da)
DK (1) DK162100C (da)
ES (1) ES8503008A1 (da)
FI (1) FI80710C (da)
GR (1) GR82048B (da)
HU (1) HU198217B (da)
IE (1) IE57425B1 (da)
IL (1) IL71870A (da)
NZ (1) NZ208174A (da)
PT (1) PT78661B (da)
SE (1) SE8303031D0 (da)
ZA (1) ZA843946B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5892068A (en) * 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
US6087522A (en) * 1999-10-12 2000-07-11 Fan Tech Corporation Silicone lanolin esters
WO2005070951A1 (en) * 2004-01-16 2005-08-04 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
MY150972A (en) * 2008-11-10 2014-03-31 Bridgestone Corp Modified natural rubber, production process for the same and rubber composition and tire prepared by using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050883A (da) *
DE1958954C3 (de) * 1969-11-24 1978-11-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Veresterung von Alkoholen
US3678082A (en) * 1970-07-30 1972-07-18 Searle & Co Esterification of 17-hydroxy steroids
GB1558472A (en) * 1976-01-22 1980-01-03 Leo Ab 17-esters of 17- hydroxy gestogens
GB1565680A (en) * 1976-12-31 1980-04-23 Leo Ab Method for the preparation of carboxylic acid esters

Also Published As

Publication number Publication date
JPH0369360B2 (da) 1991-10-31
SE8303031D0 (sv) 1983-05-30
PT78661A (en) 1984-06-01
HUT34222A (en) 1985-02-28
EP0127829A2 (en) 1984-12-12
IE57425B1 (en) 1992-09-09
DK265484D0 (da) 1984-05-29
AU560235B2 (en) 1987-04-02
US4537722A (en) 1985-08-27
PT78661B (en) 1986-06-26
EP0127829B1 (en) 1988-02-24
NZ208174A (en) 1987-04-30
ATE32603T1 (de) 1988-03-15
ES532905A0 (es) 1985-02-01
DK162100C (da) 1992-02-24
AU2883284A (en) 1984-12-06
ZA843946B (en) 1984-12-24
IE841192L (en) 1984-11-30
FI842164A0 (fi) 1984-05-30
FI80710B (fi) 1990-03-30
DE3469440D1 (en) 1988-03-31
CA1211430A (en) 1986-09-16
FI80710C (fi) 1990-07-10
IL71870A0 (en) 1984-09-30
IL71870A (en) 1986-10-31
FI842164A (fi) 1984-12-01
DK162100B (da) 1991-09-16
GR82048B (da) 1984-12-12
HU198217B (en) 1989-08-28
EP0127829A3 (en) 1985-08-07
ES8503008A1 (es) 1985-02-01
JPS6041696A (ja) 1985-03-05

Similar Documents

Publication Publication Date Title
TR200001079T2 (tr) Bisiklik kinaz inhibitörleri.
ATE380822T1 (de) Funf-helix protein
ATE28211T1 (de) Stabilisierte klebstoffe.
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
ATE54154T1 (de) Retro-inverse analoga des bradykininpotentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung.
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
DK31092D0 (da) 2-pyrimidinyl-1-piperazin-derivater, deres fremstilling og anvendelse
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
DK265484A (da) Forbedret fremgangsmaade til fremstilling af steroidestere
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
TR200101083T2 (tr) (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE59810863D1 (de) Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate
ES8505351A1 (es) Un procedimiento para preparar nuevas aroilimidazolonas
AP1579A (en) Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same.
ATE46692T1 (de) (6,11-dihydro-11-oxodibenz(b,e>oxepinyl)pentaans|uren und derivate, verfahren und zwischenprodukte zu deren herstellung und deren verwendung als arzneimittel.
ATE28892T1 (de) Verwendung von salicylsaeureestern als riechstoffe, diese enthaltende riechstoffkompositionen, sowie neue salicylsaeureester.

Legal Events

Date Code Title Description
PUP Patent expired